D.B. Root & Company, LLC
- SEC CIK
- 0001731717
- Latest filing
- Aug 13, 2026
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by D.B. Root & Company, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −4,011−100.0% | Sold out | Holders |
| Q1 2024 | 4,011 | $350.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 4,011 | $386.7K | 0.1% | −395−9.0% | Reduced | Holders |
| Q3 2023 | 4,406 | $389.8K | 0.2% | +33+0.8% | Added | Holders |
| Q2 2023 | 4,373 | $379.1K | 0.1% | +290+7.1% | Added | Holders |
| Q1 2023 | 4,083 | $397.0K | 0.2% | +10.0% | Added | Holders |
| Q4 2022 | 4,082 | $422.4K | 0.2% | −299−6.8% | Reduced | Holders |
| Q3 2022 | 4,381 | $371.0K | 0.2% | −7−0.2% | Reduced | Holders |
| Q2 2022 | 4,388 | $363.0K | 0.2% | −3,223−42.3% | Reduced | Holders |
| Q1 2022 | 7,611 | $586.0K | 0.2% | +34+0.4% | Added | Holders |
| Q4 2021 | 7,577 | $669.0K | 0.2% | −152−2.0% | Reduced | Holders |
| Q3 2021 | 7,729 | $597.0K | 0.2% | −1,521−16.4% | Reduced | Holders |
| Q2 2021 | 9,250 | $771.0K | 0.3% | −82−0.9% | Reduced | Holders |
| Q1 2021 | 9,332 | $704.0K | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.